-
Osaikang Pharmaceutical's dexrazoxane for injection has been approved
Time of Update: 2021-03-27
On March 17, the official website of the State Administration of Food and Drug Administration showed that Jiangsu Aosaikang Pharmaceutical's dexrazoxane for injection was approved for listing in imitation 3 categories, and it was deemed to have been reviewed.
-
Indian Prime Minister Modi vaccinated the first dose of the new crown vaccine, which was developed locally in India
Time of Update: 2021-03-27
Modi said that through the efforts of Indian doctors and scientists, India was able to quickly develop a vaccine and strongly supported the global fight against the new crown pneumonia epidemic.
-
Sinopharm: Medical Device Annual Revenue Announcement
Time of Update: 2021-03-27
Facing the national centralized procurement, the latest strategy is announced According to the announcement of Sinopharm Holdings, in 2020, the strict prevention and control measures adopted by hospitals will restrict the development of daily medical operations and hospitalization services, which will have a phased impact on the sales and product structure of the medical device business.
-
New ADC drug Padcev applies for marketing in Japan: treats patients refractory to PD-(L)1 inhibitors
Time of Update: 2021-03-27
The Phase 3 EV-301 confirmatory trial was conducted in adult patients with locally advanced or metastatic urothelial carcinoma who had previously received platinum-based chemotherapy and a PD-1/L1 inhibitor, comparing Padcev with chemotherapy.
-
Eli Lilly's antibody bamlanivimab is discontinued in three U.S. states
Time of Update: 2021-03-27
Previously, the US FDA had instructed Eli Lilly and its antibody development partner Regeneron to track virus mutations.
Eli Lilly's Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says2.
-
China's new coronavirus therapeutic antibody drug is approved for emergency use in Europe and the United States
Time of Update: 2021-03-27
The institute stated that this indicates that the safety and effectiveness of new coronavirus-specific antibody drugs with China's independent intellectual property rights have been recognized by the world.
-
A pharmaceutical company was warned for failing to comply with GMP during the inspection process
Time of Update: 2021-03-27
Violation of "Pharmaceutical Production Quality Management Regulations"The on-site inspection of Fujian Minghua Pharmaceutical Co.
-
Aide Biotech and Haihe Pharmaceutical reached a targeted drug clinical research cooperation
Time of Update: 2021-03-27
On March 12, 2021, Aide Bio announced that it has reached a targeted drug clinical research cooperation with Haihe Pharmaceuticals, and the company’s self-developed "MET detection kit" will serve as a
-
Luoxin Pharmaceutical Subsidiary Omeprazole Sodium for Injection Passed the Consistency Evaluation
Time of Update: 2021-03-27
("Shandong Luoxin") had recently received the approval and issue of Ogilvy for Injection from the National Medical Products Administration.
The omeprazole sodium for injection developed by Shandong Luoxin was first approved for marketing in 2005.
-
CDE intends to identify Hengrui CDK4/6 inhibitors and Junshi anti-PD-1 for breakthrough therapy
Time of Update: 2021-03-27
In August 2019, Junshi announced the results of an open-label phase IB clinical trial of teriprizumab combined with the anti-angiogenic drug axitinib for the treatment of advanced mucosal melanoma.
-
AstraZeneca's CLL drug Calquence is approved by NICE in the UK
Time of Update: 2021-03-27
CompilationFan DongdongA few days ago, the National Institute of Health and Clinical Optimization (NICE) decided to recommend AstraZeneca’s BTK inhibitor Calquence (Acalabrutinib) into the British National Health Service (NHS) for the treatment of certain adult chronic lymphocytic leukemia (CLL).
-
Application of Dominant Fragment Hybridization Strategy in Drug Development
Time of Update: 2021-03-27
Later, through molecular docking and hybridization strategies of dominant fragments, other researchers discovered that new pyridine amide and pyridone derivatives have strong inhibitory activity against HIV.
-
Dongyangguang: Application for drug registration of insulin aspart injection has been accepted
Time of Update: 2021-03-27
(hereinafter referred to as "Dongyang Pharmaceutical") insulin aspart injection had received the "Notice of Acceptance" issued by the State Food and Drug Administration.
According to Ai Kunwei data, in 2019, China's diabetes drug sales amount is approximately 3.
-
Tylenol Microlab TNM002 monoclonal antibody successfully obtained IND approval from the US FDA
Time of Update: 2021-03-27
, referred to as “Tinomab” and “Trinomab”) announced its self-developed recombinant anti-tetanus toxin monoclonal antibody drug TNM002 Its clinical trial application (IND) was officially approved by the U.
TNM002 is a natural and fully human monoclonal antibody drug developed by Trinomab using its HitmAb® technology platform with independent intellectual property rights.
-
The new requirements of the Health Commission affect a large number of secondary hospitals!
Time of Update: 2021-03-27
The "Task" clarified that, in order to improve the mental health service capabilities of medical institutions, 100% psychiatric hospitals in the pilot area have set up mental outpatient clinics, and 40% of general hospitals above the second level open mental (psychological) outpatient clinics.
-
AstraZeneca announces the latest phase 3 clinical results of the new crown vaccine
Time of Update: 2021-03-27
The Data Safety Monitoring Committee found no increased risk of thrombosis in 21,583 subjects who received at least one dose of the vaccine, and no CVST event was found in this clinical trial.
-
Eli Lilly's basal insulin BIF has a hypoglycemic effect comparable to Novo Nordisk insulin
Time of Update: 2021-03-27
CompilenewbornAccording to a phase 2 clinical trial (NCT03736785), a new once-a-week basal insulin injection has similar efficacy and safety compared with once-a-day basal insulin, and has a lower incidence of hypoglycemia.
-
The first domestic epothilone class 1 new drug Utidelon injection is about to be approved
Time of Update: 2021-03-27
Among them, CTR20150579 is a phase III clinical study aimed at evaluating UTD1 injection combined with capecitabine in the treatment of patients with advanced metastatic breast cancer.
-
Where is the next leap in CAR-T therapy? Cinda Bio and other Chinese companies explore new directions
Time of Update: 2021-03-27
According to the official website of Reindeer Medical, for patients with relapsed/refractory multiple myeloma, high-dose BCMA targeted CAR-T cell therapy may provide better remission, but the adverse events are more serious.
-
Fuan Pharmaceutical: Cefminox sodium for injection passed the consistency evaluation
Time of Update: 2021-03-27
, has recently received a supplementary drug application approval notice issued by the National Medical Products Administration, and its product Cefminox sodium for injection has passed The quality and efficacy consistency evaluation of generic drugs.
Cefminox sodium for injection is an anti-infective drug.
